Ratos AB OMXSTO:RATO_A:
TFS HEALTHSCIENCE PARTNERS WITH VERIGRAFT FOR PHASE II/III P-TEV TRIAL
Ratos Company TFS HealthScience Supports Trial For Novel Vascular Therapy
Earlier from Ratos Ab Class A
- Dr. Holger Rubel appointed Chairman in LEDiL
- RATO_A: Q1 delivered strong growth and margin gains, with strategy execution and positive Q2 outlook
- Ratos – Consensus estimates Q1 2026
- Invitation to the presentation of Ratos Interim report January-March 2026